Facebook PixelWet AMD: treating the cause or the effect?
Create newCreate new
Sessions onlySessions only
Ideas onlyIdeas only
Brainstorming session

Wet AMD: treating the cause or the effect?

Image credit: http://advaitatoons.blogspot.com/2005/11/cause-and-effect-duality-illustrated.html

Shubhankar Kulkarni
Shubhankar Kulkarni Jul 30, 2020
Creative contributions

Antiangiogenic & Alpha-lipoic Therapies

Mohammad Shazaib
Mohammad Shazaib Oct 02, 2020

[1]1. Velez-Montoya R., Oliver S. C. N., Olson J. L., Fine S. L., Mandava N., Quiroz-Mercado H. Current knowledge and trends in age-related macular degeneration: today’s and future treatments. Retina. 2013;33(8):1487–1502

[2]Salvi S. M., Akhtar S., Currie Z. Ageing changes in the eye. Postgraduate Medical Journal. 2006;82(971):581–587

[3]Ashraf M., Souka A. A. R. Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option. Eye. 2017;31(11):1523–1536

[4]Hahn P., Milam A. H., Dunaief J. L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch’s membrane. Archives of Ophthalmology. 2003;121(8):1099–1105

[5]Shaw P. X., Hörkkö S., Chang M. K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. The Journal of Clinical Investigation. 2000;105(12):1731–1740

[6] Hanus J., Zhao F., Wang S. Current therapeutic developments in atrophic age-related macular degeneration. British Journal of Ophthalmology. 2016;100(1):122–127

Add your creative contribution

0 / 200

Added via the text editor

Sign up or


Guest sign up

* Indicates a required field

By using this platform you agree to our terms of service and privacy policy.

General comments